What Galera Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 1 |
| Total trades | 5 | 11 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 37,499,488 |
| Disposed | 90,091 | 230,091 |
| Net activity | −90,091 | +37,269,397 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Sorensen Mel | President and CEO | Aug 03 | Disposition to Issuer · D | −975 | — | — | 0 |
| Friedman Michael R. | Director | Aug 03 | Disposition to Issuer · D | −41,631 | — | — | 0 |
| Alleva Lawrence M | Director | Aug 03 | Disposition to Issuer · D | −40 | — | — | 0 |
| Alleva Lawrence M | Director | Aug 03 | Disposition to Issuer · D | −11 | — | — | 0 |
| Chang Nancy T | Director | Aug 03 | Disposition to Issuer · D | −47,434 | — | — | 0 |
| Friedman Michael R. | Director | May 15 | Derivative Conversion · C | +2,989,399 | — | — | 8,326,269 |
| Chang Nancy T | Director | May 15 | Derivative Conversion · C | +661,309 | — | — | 9,486,852 |
| Emerald Bioventures, Llc | 10% owner | May 15 | Derivative Conversion · C | +20,813,818 | — | — | 61,029,978 |
| Friedman Michael R. | Director | Apr 07 | Derivative Conversion · C | +5,336,870 | — | — | 5,336,870 |
| Chang Nancy T | Director | Apr 07 | Derivative Conversion · C | +1,180,611 | — | — | 8,825,543 |
| Sorensen Mel | President and CEO | Nov 20 | Open-market sale · S | −70,000 | $0.02 | −$1.41K | 195,029 |
| Chang Nancy T | Director | Dec 30 | Open-market buy · P | +7,644,932 | $0.07 | +$500K | 7,644,932 |
| Sorensen Mel | President and CEO | Aug 16 | Open-market sale · S | −67,015 | $0.07 | −$4.83K | 265,029 |
| Schneid Yair | 10% owner | Apr 19 | Open-market buy · P | +99,371 | $0.19 | +$19.3K | 10,823,610 |
| Schneid Yair | 10% owner | Apr 19 | Open-market buy · P | +215 | $0.19 | +$40.3 | 10,724,239 |
| Schneid Yair | 10% owner | Apr 19 | Open-market buy · P | +314 | $0.19 | +$58.8 | 10,724,024 |
| Schneid Yair | 10% owner | Apr 19 | Open-market buy · P | +100 | $0.19 | +$18.6 | 10,723,710 |
| Schneid Yair | 10% owner | Apr 18 | Open-market buy · P | +4,245 | $0.20 | +$848 | 10,645,066 |
| Schneid Yair | 10% owner | Apr 18 | Open-market buy · P | +247,600 | $0.20 | +$49K | 10,640,821 |
| Schneid Yair | 10% owner | Apr 18 | Open-market buy · P | +100,000 | $0.20 | +$19.7K | 10,393,221 |
Loading...
